GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,512 Cr | ₹2,572 Cr | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹2,512 Cr |
| Mar2025 | ₹2,572 Cr |
| Mar2024 | ₹2,545 Cr |
| Mar2023 | ₹2,447 Cr |
| Mar2022 | ₹2,516 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,512 Cr | -2.31 | |
| Mar2025 | ₹2,572 Cr | 1.05 | |
| Mar2024 | ₹2,545 Cr | 3.99 | |
| Mar2023 | ₹2,447 Cr | -2.73 | |
| Mar2022 | ₹2,516 Cr | - | |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,288.6 Cr | 1.7% | 10.2% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.7% |
10.2% |
6.5% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses